Altimmune (ALT) Current Assets: 2010-2025
Historic Current Assets for Altimmune (ALT) over the last 15 years, with Sep 2025 value amounting to $216.6 million.
- Altimmune's Current Assets rose 48.61% to $216.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $216.6 million, marking a year-over-year increase of 48.61%. This contributed to the annual value of $137.3 million for FY2024, which is 34.52% down from last year.
- According to the latest figures from Q3 2025, Altimmune's Current Assets is $216.6 million, which was up 14.96% from $188.4 million recorded in Q2 2025.
- In the past 5 years, Altimmune's Current Assets ranged from a high of $245.2 million in Q1 2021 and a low of $137.3 million during Q4 2024.
- For the 3-year period, Altimmune's Current Assets averaged around $173.4 million, with its median value being $171.2 million (2024).
- Its Current Assets has fluctuated over the past 5 years, first surged by 518.59% in 2021, then plummeted by 34.52% in 2024.
- Altimmune's Current Assets (Quarterly) stood at $204.1 million in 2021, then dropped by 5.54% to $192.8 million in 2022, then climbed by 8.72% to $209.6 million in 2023, then plummeted by 34.52% to $137.3 million in 2024, then surged by 48.61% to $216.6 million in 2025.
- Its Current Assets was $216.6 million in Q3 2025, compared to $188.4 million in Q2 2025 and $155.3 million in Q1 2025.